“…[64][65][66][67] Higher expression of Laminin-332 in HCC than in normal or peritumoral tissue, association with metastatic phenotype 68 Periostin Periostin interacts with integrins αvβ3, αvβ5, and α6β4, resulting in the activation Akt/PKB and FAK-mediated signaling pathways as well as increased EGFR activation. [69][70][71] Periostin induces stemness in HCC 78 Periostin is upregulated in multiple cancers including HCC and associated with poor outcomes 72,75,76 Growth factors HGF Binds to its receptor Met, resulting in the activation of multiple kinase pathways such as Erk, Akt, and NF-κB 185,255 Promotes hepatocyte proliferation and survival; in HCC, HGF increases tumor migration, neoangiogenesis, proliferation, 180,183,256,257 and chemoresistance. 17 73 Periostin is upregulated in multiple cancers including HCC and associated with poor outcomes.…”